Rhabdomyolysis after LSD ingestion

Psychosomatics

Volumn 51, Issue 4, 2010, Pages

  Berrens, Zachary ^a   Lammers, Jessica ^a   White, Christopher ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Dept of Psychiatry ^*

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BICARBONATE; COCAINE; LYSERGIDE; CREATINE KINASE; PSYCHEDELIC AGENT; SODIUM CHLORIDE;

ADULT; AGITATION; ARTICLE; CASE REPORT; CONSULTATION; HUMAN; INGESTION; INTOXICATION; MALE; MENTAL HEALTH; MUSCLE WEAKNESS; MYALGIA; PSYCHIATRIST; RHABDOMYOLYSIS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECT; FLUID THERAPY; PROCEDURES;

ADULT; CREATINE KINASE; FLUID THERAPY; HALLUCINOGENS; HUMANS; LYSERGIC ACID DIETHYLAMIDE; MALE; RHABDOMYOLYSIS; SODIUM BICARBONATE; SODIUM CHLORIDE;

EID: 77955641206     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1176/appi.psy.51.4.356     Document Type: Article

References (20)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Results From the 2008 National Survey on Drug Use and Health: National Findings. Pub. No. SMA 08-4343, Dept. of Health and Human Services, Rockville, MD, 2008
2. U.S. Dept. of Health and Human Services Department Visits, Substance Abuse and Mental Health Services Administration: National Estimates of Drug-Related Emergency. Drug Abuse Warning Network. Available at http://dawninfo.samhsa.gov/files/ED2006/DAWN2k6ED.pdf
3. Blaho K, Merigian K, Winbery S, et al: Clinical pharmacology of lysergic acid diethylamide: case reports and review of the treatment of intoxication. Am J Ther 1997; 4(5-6):211-221 (Pubitemid 27263927)
4. Passie T, Halpern JH, Stichtenoth DO, et al: The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther 2008; 14:295-314
5. Huerta-Alardín AL, Varon J, Marik PE: Bench-to-bedside review: rhabdomyolysis: an overview for clinicians. Crit Care 2005; 9:158-169 (Pubitemid 40425441)
6. Moghtader J, Brady W, Bonadio W: Exertional rhabdomyolysis in an adolescent athlete. Pediatr Emerg Care 1997; 13:382-385
7. Gabow PA, Kaehny WD, Kelleher SP: The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61:141-152
8. Bagley WH, Yang H, Shah KH: Rhabdomyolysis. Intern Emerg Med 2007; 2:210-218
9. Bosch X, Poch E, Grau JM: Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361:62-72
10. Fernandez WG, Hung O, Bruno GR, et al: Factors predictive of acute renal failure and need for hemodialysis among ED patients with rhabdomyolysis. Am J Emerg Med 2005; 23:1-7
11. Fernandez-Funez A, de Tomas E, Alamillo A, et al: Nontraumatic rhabdomyolysis: its etiology and the predictive factors of acute kidney failure. Med Clin (Barcelona) 1995; 105:412-415
12. Sinert R, Kohl L, Rainone T, et al: Exercise-induced rhabdomyolysis. Ann Emerg Med 1994; 23:1301-1306
13. de Meijer AR, Fikkers BG, de Keijzer MH, et al: Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive-care survey. Intens Care Med 2003; 29:1121-1125
14. Mercieca J, Brown EA: Acute renal failure due to rhabdomyolysis associated with use of a straitjacket in lysergide intoxication. Br Med J (Clin Res Ed) 1984; 288(6435):1949-1950 (Pubitemid 14081769)
15. Harding T: The effect of lysergic acid diethylamide on serum creatine kinase levels. Psychopharmacologia (Berlin) 1974; 40: 177-184
16. Behan WM, Barkheit AM, Behan PO, et al: The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide. J Neurol Neurosurg Psychiatry 1991; 54:741-743
17. Warren J, Blumberg P, Thompson P: Rhabdomyolysis: a review. Muscle Nerve 2002; 25:332-347
18. Curry SC, Chang D, Connor D: Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 1989; 18:1068-1084
19. Boyer EW, Shannon M: Current concepts: the serotonin syndrome. New Engl J Med 2005; 352:1112-1120
20. Meltzer, H: Creatine kinase and aldolase in serum: abnormality common to acute psychoses. Science 1968; 159:1368-1370